Y-mabs therapeutics, inc. class action alert: wolf haldenstein adler freeman & herz llp reminds investors that a securities class action lawsuit has been filed in the united states district court for the southern district of new york against y-mabs therapeutics, inc.

Lead plaintiff deadline is march 20, 2023 new york , feb. 14, 2023 /prnewswire/ -- wolf haldenstein adler freeman & herz llp announces that a federal securities class action lawsuit has been filed in the united states district court for the southern district of new york on behalf of investors who purchased or otherwise acquired y-mabs therapeutics, inc. ("y-mabs" or the "company") (nasdaq: ymab) common stock between october 6, 2020 and october 28, 2022, inclusive (the "class period"). a ll investors who purchased shares and incurred losses are  advised  to contact the firm immediately at classmember@whafh.com or (800) 575-0735 or (212) 545-4774.
YMAB Ratings Summary
YMAB Quant Ranking